Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05617105

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Conditions: Perivascular Epithelioid Cell Tumor, Malignant

Sex: All
Ages: 1 Year – N/A
Enrollment: 100
Sponsor: University Hospital, Strasbourg, France

Location: France

Summary

Perivascular epithelioid cell tumors (PEComas) are rare and are characterized by the expression of myomelanocytic markers. They are a complex family that includes angiomyolipomas, lymphangioleiomyomatoses and other soft tissue and visceral tumors. Due to the low prevalence of these tumors, the natural history is unclear; furthermore, a molecular classification integrating clinical, pathological and molecular parameters has not been described to date.

Eligibility Criteria

Inclusion criteria:Major patient (≥18 years)Minor patient (1 to 17 years old)PEComas diagnosed in France between 01/01/1990 and 15/09/2019 and reviewed by a sarcoma referral pathologistExclusion criteria :Opposition of the patient (or the holders of parental authority) to participate in the studyBiological tissue from a patient who does not meet all the inclusion criteriaClassic triphasic angiomyolipoma or lymphangioleiomyomatosisInability to provide informed information to the subjectPatient under court protectionPatient under guardianship or curatorship

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05617105). StuddyBuddy aggregates publicly available trial information.